CX3CR1 and coronary artery disorder: The percentage of CD14+CD16+CX3CR1+ monocytes in UAP patients treated with statins was previously reported to be lower than that in patients without statins (63), and the number of CCR5+ monocytes in CAD patients decreased significantly among the 3 subsets (20).